The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bristol-Myers Squibb; Leo Pharma; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; Roche
A phase I dose-escalation and expansion study of intratumoral CV8102 as single-agent or in combination with anti-PD-1 antibodies in patients with advanced solid tumors.
 
Thomas Eigentler
No Relationships to Disclose
 
Franz G Bauernfeind
Honoraria - Bristol-Myers Squibb; Roche; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Roche; Takeda
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Celgene; Gilead Sciences
 
Jürgen C. Becker
Consulting or Advisory Role - Amgen; eTheRNA; InProTher; Merck Serono; Sanofi/Regeneron
Speakers' Bureau - Amgen; Merck Serono; Novartis; Sanofi/Regeneron
Research Funding - Alcedis (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); IQvia (Inst); Merck Serono (Inst)
Travel, Accommodations, Expenses - 4SC; Merck Serono
 
Peter Brossart
Honoraria - Bristol-Myers Squibb; MSD
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; MSD; Roche
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD
 
Michael Fluck
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pierre Fabre
 
Lucie Heinzerling
Consulting or Advisory Role - BMS, MAS, Sanofi, Pierre Fabre, Amgen, Curevac, Roche, Novartis
Research Funding - Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Predictive and soluble prognostic biomarker
 
Jürgen Krauss
Consulting or Advisory Role - Vaccibody; Vaccibody (Inst)
 
Peter Mohr
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche/Genentech; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Research Funding - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche; Sun Pharma
 
Sebastian Ochsenreither
Honoraria - AstraZeneca; Bristol-Myers Squibb; Ipsen; Merck Serono; MSD
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; CureVac; Janssen-Cilag; Merck Serono; MSD
Research Funding - Bristol-Myers Squibb
Patents, Royalties, Other Intellectual Property - Cyclin A1 as T-cell target
Travel, Accommodations, Expenses - Ipsen; Merck Serono
 
Jutta Sylvina Schreiber
Honoraria - Bristol-Myers Squibb; Merck Serono
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono
Expert Testimony - Bristol-Myers Squibb; Merck Serono
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono
 
Patrick Terheyden
Honoraria - Biofrontera; Bristol-Myers Squibb; CureVac; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Merck KGaA; Novartis; Pierre Fabre; Roche; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Pierre Fabre
 
Benjamin Weide
Consulting or Advisory Role - Philogen
Research Funding - Bristol-Myers Squibb (Inst); Philogen (Inst)
 
Carsten Weishaupt
Honoraria - Amgen; Bristol-Myers Squibb; Curevac; LEO Pharma; MSD; Novartis; Pierre Fabre; Roche Pharma AG; Teva
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Takeda
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Novartis
 
Fatma Funkner
Employment - CureVac
 
Anke Muth
Employment - CureVac
 
Sarah-Katharina Kays
Employment - CureVac
 
Claudia Stosnach
Employment - CureVac
 
Angelika Daehling
Employment - CureVac
 
Gianluca Quintini
Employment - CureVac
 
Senta Ulrike Gnad-Vogt
Employment - CureVac
Leadership - CureVac
Stock and Other Ownership Interests - Bristol-Myers Squibb
Honoraria - CureVac
Patents, Royalties, Other Intellectual Property - CureVac